Jane Street Group, LLC Catalent, Inc. Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $3.67 Million - $3.98 Million	65,300 New	65,300 $3.96 Million
Q1 2022 May 17, 2022	BUY	$94.19 - $124.49 $12.2 Million - $16.2 Million	129,800 Added 374.06%	164,500 $18.2 Million
Q4 2021 Feb 15, 2022	SELL	$119.57 - $139.07 $6.72 Million - $7.82 Million	-56,200 Reduced 61.83%	34,700 $4.44 Million
Q3 2021 Nov 16, 2021	SELL	$109.17 - $142.35 $1.38 Million - $1.79 Million	-12,600 Reduced 12.17%	90,900 $12.1 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $2.76 Million - $3.18 Million	27,500 Added 36.18%	103,500 $11.2 Million
Q1 2021 May 18, 2021	BUY	$101.51 - $125.27 $4.26 Million - $5.26 Million	42,000 Added 123.53%	76,000 $8 Million
Q4 2020 Feb 17, 2021	BUY	$85.88 - $105.36 $1.27 Million - $1.56 Million	14,800 Added 77.08%	34,000 $3.54 Million
Q3 2020 Nov 17, 2020	SELL	$72.74 - $92.5 $1.55 Million - $1.97 Million	-21,300 Reduced 52.59%	19,200 $1.65 Million
Q2 2020 Aug 17, 2020	BUY	$48.02 - $79.04 $1.94 Million - $3.2 Million	40,500 New	40,500 $2.97 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.